Bank of Nova Scotia
AMRI

Bank of Nova Scotia’s Albany Molecular Research Inc AMRI Stock Holding History

Bank of Nova Scotia’s Portfolio AMRI Stock Details AMRI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-39,090
Closed -$848K – 1027
2017
Q2 		$848K Buy
39,090
+2,300
+6% +$41.7K ﹤0.01% 787
2017
Q1 		$516K Buy
36,790
+3,120
+9% +$51.1K ﹤0.01% 811
2016
Q4 		$632K Hold
33,670
– – ﹤0.01% 561
2016
Q3 		$556K Hold
33,670
– – ﹤0.01% 503
2016
Q2 		$452K Hold
33,670
– – ﹤0.01% 515
2016
Q1 		$515K Buy
33,670
+2,300
+7% +$36K ﹤0.01% 469
2015
Q4 		$623K Hold
31,370
– – ﹤0.01% 466
2015
Q3 		$546K Buy
31,370
+12,270
+64% +$250K ﹤0.01% 409
2015
Q2 		$386K Hold
19,100
– – ﹤0.01% 421
2015
Q1 		$336K Buy
19,100
+8,400
+79% +$143K ﹤0.01% 451
2014
Q4 		$174K Sell
10,700
-2,300
-18% -$42.2K ﹤0.01% 548
2014
Q3 		$286K Hold
13,000
– – ﹤0.01% 456
2014
Q2 		$261K Hold
13,000
– – ﹤0.01% 474
2014
Q1 		$241K Hold
13,000
– – ﹤0.01% 508
2013
Q4 		$131K Buy
+13,000
New +$157K ﹤0.01% 567

Other funds holding AMRI

AA
Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

Bank of Nova Scotia's AMRI Position: Q3 2017 in Review

Bank of Nova Scotia sold out of Albany Molecular Research Inc (AMRI) in Q3 2017, closing a stake of 39,090 shares — an estimated $848K sold.

Bank of Nova Scotia first reported a position in AMRI in Q4 2013 and held it in 15 quarters. The position peaked at $848K in Q2 2017. 2 funds tracked by Wall St. Rank hold AMRI as of Q3 2017.

  • Bank of Nova Scotia reported no remaining Albany Molecular Research Inc position as of Q3 2017 after selling out during the quarter.
  • Bank of Nova Scotia sold 39,090 Albany Molecular Research Inc shares in Q3 2017, an estimated $848K.
  • Bank of Nova Scotia first reported a position in Albany Molecular Research Inc in Q4 2013 and held it in 15 quarters.
  • Bank of Nova Scotia's Albany Molecular Research Inc position peaked at $848K in Q2 2017.
  • 2 funds tracked by Wall St. Rank held Albany Molecular Research Inc as of Q3 2017.

Based on Bank of Nova Scotia's 13F filing for Q3 2017, filed 14 Nov 2017.